Anti-Smad3 antibody [EP568Y]
- 20ul selling size
- Recombinant
- KO Validated
- Advanced Validation
- RabMAb
- What is this?
5
(10 Reviews)
|
(401 Publications)
Anti-Smad3 antibody [EP568Y] (ab40854) is a rabbit monoclonal antibody detecting Smad3 in Western Blot, Flow Cytometry (Intra), ICC/IF, ELISA. Suitable for Human, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 300 publications
- Trusted since 2006
View Alternative Names
MADH3, SMAD3, SMAD family member 3, SMAD 3, hSMAD3, JV15-2, Mothers against decapentaplegic homolog 3, MAD homolog 3, Mad3, Mothers against DPP homolog 3, hMAD-3
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Smad3 antibody [EP568Y] (AB40854)
Intracellular Flow Cytometry analysis of HT-29 cells labelling Smad3 with purified ab40854 at 1/210 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Green - Isotype control, rabbit monoclonal IgG.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Smad3 antibody [EP568Y] (AB40854)
Overlay histogram showing HCT116 cells stained with unpurifiedab40854 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40854, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Smad3 antibody [EP568Y] (AB40854)
Immunocytochemsitry/Immunofluorescence analysis of HepG2 cells labelling Smad3 (green) with purified ab40854 at 1/2000 . Cells were fixed with 4% paraformaldehyde. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/200) was used as the secondary antibody (green, left panel). Counterstained with DAPI (blue, right panel).
- ICC/IF
AbReview43264****
Immunocytochemistry/ Immunofluorescence - Anti-Smad3 antibody [EP568Y] (AB40854)
ab40854 staining Smad3 in human granulosa cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with paraformaldehyde, permeabilized with ethanol and triton and blocked for 1 hour at 26°C. Samples were incubated with primary antibody (1/200) for 16 hours at 4°C. An undiluted IRDye® 800CW-conjugated goat anti-rabbit IgG (H+L) polyclonal was used as the secondary antibody. Left - negative control (4 replicates).
This image is courtesy of an Abreview submitted by Francesco Elia Marino
- WB
Lab
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
False colour image of Western blot : Anti-Smad3 antibody [EP568Y] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40854 was shown to bind specifically to Smad3. A band was observed at 50 kDa in wild-type A549 cell lysates with no signal observed at this size in SMAD3 CRISPR-Cas9 edited cell line ab277888 (CRISPR-Cas9 edited cell lysate None). The band observed in the CRISPR-Cas9 edited lysate lane below 50 kDa is likely to represent a truncated form of Smad3. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and SMAD3 CRISPR-Cas9 edited A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Western blot - Human SMAD3 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-smad3-knockout-a549-cell-line-ab277888'>ab277888</a>)
Lane 2:
SMAD3 CRISPR-Cas9 edited A549 cell lysate at 20 µg
Secondary
Lanes 1 - 2:
Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 2:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 48 kDa
Observed band size: 50 kDa
false
- WB
Lab
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
Lanes 1 - 4 : Merged signal (red and green). Green - ab40854 observed at 48 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab40854 was shown to react with Smad3 in western blot. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab40854 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/1000 dilution
Lane 1:
Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human SMAD3 knockout A549 cell lysate (<a href='/en-us/products/cell-lysates/human-smad3-knockout-a549-cell-lysate-ab264513'>ab264513</a>)
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
Human Kidney cell lysate at 20 µg
Predicted band size: 48 kDa
Observed band size: 50 kDa
false
- WB
Lab
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/5300 dilution
Lane 1:
HT-29 cell lysate at 10 µg
Lane 2:
HT-1080 cell lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 58 kDa
false
- WB
Lab
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
This blot was produced using 4-20% SDS-PAGE containing 15 μg of HT-29 whole cell lysate per lane at 150V for 1hr before being transferred onto a 0.45 μm PVDF membrane at 75V for 1hr. The membrane was then blocked for 1hr using 5% NFDM/TBST, then incubated with ab40854 (1/5000) at room temperature for 1hr. After being washed three times in TBST, the membrane was incubated with Peroxidase conjugated goat anti-rabbit IgG (H+L) (ab97051) at 1/20,000 dilution for 1hr at room temperature. The membrane was washed three times again. Then the signal was developed using the ECL technique. ab40854 was stored at a range of temperatures (+4°C, +22°C, +37°C) for 1 week before being tested in WB. The image shows the band intensity remains relatively constant across all storage temperatures, demonstrating that antibody activity is not affected.
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/5000 dilution
All lanes:
HT-29 whole cell lysate at 15 µg with NDFM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 10s
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad3 antibody [EP568Y] (AB40854)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 A549 (Human lung carcinoma cell line) cells treated with hTGF-β1 (7 ng/mL 1 h) and 5 µg of ab40854 [EP568Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad3 antibody [EP568Y] (AB40854)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700ng/mL, 2.5 x 10^5 A549 (Human lung carcinoma cell line) cells treated with hTGF-β1 (7 ng/mL 1 h) and 5 µg of ab40854 [EP568Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-Smad3 antibody [EP568Y] (AB40854)
CUT&RUN profiling with Smad3 antibody reveals the expected genomic enrichment pattern in cells. Representative genome browser tracks show CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with Smad3 antibody (Abcam ab40854, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG, H3K4me3, and H3K27me3 antibodies were included as controls to assess non-specific background, active promoters, and repressed chromatin, respectively. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Images were generated using Integrative Genomics Viewer (IGV, Broad Institute).
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-Smad3 antibody [EP568Y] (AB40854)
CUT&RUN profiling with Smad3 antibody demonstrates robust genome-wide enrichment in cells. Heatmaps of genome-wide signal flanking annotated transcription start sites (TSSs, +/- 2 kbp) display CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with Smad3 antibody (Abcam ab40854, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG antibody was included as a negative control to assess non-specific background. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Heatmaps were generated using ChAsE (Younesy et al., Bioinformatics 2016; PMID 27378294). Row-linked data are ranked by intensity relative to Smad3, with red indicating high localized enrichment and blue denoting background.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-Smad3 antibody [EP568Y] (AB40854)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 A549 (Human lung carcinoma cell line) cells treated with hTGF-β1 (7 ng/mL 1 h) and 5 µg of ab40854 [EP568Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/5300 dilution
All lanes:
Rat liver tissue lysate at 10 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 58 kDa
false
- sELISA
Unknown
Sandwich ELISA - Anti-Smad3 antibody [EP568Y] (AB40854)
Standard Curve for Smad3 (Analyte : Smad3 protein (His tag) (ab89353, unpurified)); dilution range 1pg/ml to 1μg/ml using Capture Antibody Mouse monoclonal [AF9F7] to Smad3 (ab75512) at 5μg/ml and Detector Antibody Rabbit monoclonal [EP568Y] to Smad3 (ab40854) at 0.5μg/ml.
- WB
Unknown
Western blot - Anti-Smad3 antibody [EP568Y] (AB40854)
All lanes:
Western blot - Anti-Smad3 antibody [EP568Y] (ab40854) at 1/5000 dilution
All lanes:
Jurkat cell lysate at 10 µg
Predicted band size: 48 kDa
Observed band size: 55 kDa
false
Related conjugates and formulations (7)
-
Anti-Smad3 antibody [EP568Y] - BSA and Azide free
-
578 PE
PE Anti-Smad3 antibody [EP568Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Smad3 antibody [EP568Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Smad3 antibody [EP568Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Smad3 antibody [EP568Y]
-
HRP Anti-Smad3 antibody [EP568Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Smad3 antibody [EP568Y]
Reactivity data
Product details
What is this antibody validated in?
Anti-Smad3 antibody [EP568Y] (ab40854) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, Rat samples.
What is the molecular weight of Smad3?
Anti-Smad3 [EP568Y] (ab40854) specifically detects a band for Smad3 (UniProt: P84022) at a molecular weight of 48kDa.
Trusted by the scientific community
Anti-Smad3 [EP568Y] (ab40854) was first used in a scientific publication in 2006 and has been cited over 300 times in peer-reviewed journals.
Reviewed by scientists
Anti-Smad3 [EP568Y] (ab40854) has over 10 independent reviews from customers.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-Smad3 antibody [EP568Y] (ab40854) has been confirmed by Western blot testing in SMAD3 Knockout A549 cells.
Other related products
We have a range of other formats of antibody clone [EP568Y] also available for your convenience: ab40854, Carrier free - ab157372, Alexa Fluor® 488 - ab204257, Alexa Fluor® 647 - ab204461, HRP - ab204462, Alexa Fluor® 594 - ab206350, Alexa Fluor® 555 - ab206582, PE - ab208751
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Shipping conditions update: ambient shipping
This product will be delivered at ambient temperature instead of chilled – this is by design. Extensive stability testing confirmed that our products are suitable for shipment under ambient conditions and maintain expected quality.
Why the change?
It’s part of our commitment to more sustainable packaging solutions, with ambient deliveries using eco-friendly materials such as recyclable cardboard instead of polystyrene.
What you need to know
- Ambient shipments come clearly marked on the delivery note.
- No ice will be included in ambient shipments, but mixed orders (ambient and cold-chain items) will still arrive with ice packs to protect temperature-sensitive products.
- Warranty coverage remains fully valid, aligned with our validated shipping method.
- Please store the product as per the datasheet instructions upon receipt.
Find out more - https://www.abcam.com/en-us/support/shipping-storage-support/ambient-shipping
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad3 acts as a mediator of signal transduction for the TGF-beta (transforming growth factor-beta) superfamily forming a complex with phosphorylated Smad2. This enables it to regulate transcriptional activity influencing cell proliferation differentiation and apoptosis. Smad3 also participates in various cellular processes by interacting with other co-factors and regulatory proteins that aid in fine-tuning its function.
Pathways
Smad3 plays an important role in the TGF-beta signaling pathway where it works closely with Smad4 to propagate the signal. Upon phosphorylation it forms a complex with co-Smad (Smad4) and moves into the nucleus to influence gene expression. Smad3 is also involved in pathways related to oncogenesis and tissue fibrosis indicating its significant role in cellular regulation and response mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (401)
Recent publications for all applications. Explore the full list and refine your search
Chinese medicine 20:135 PubMed40883748
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 647:517-527 PubMed40866703
2025
Applications
Unspecified application
Species
Unspecified reactive species
Iranian journal of biotechnology 23:e4098 PubMed40860053
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 33:2075-2084 PubMed40746879
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:27263 PubMed40715596
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 32: PubMed40539440
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell communication and signaling 19:e70025 PubMed40520075
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:18460 PubMed40425777
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:179 PubMed40380175
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:372 PubMed40348745
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com